IGC Pharma
IGC
#10699
Rank
โ‚น2.45 B
Marketcap
โ‚น23.78
Share price
1.59%
Change (1 day)
-35.50%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

IGC Pharma (IGC) - Cash on Hand

Cash on Hand as of March 2026 : โ‚น22.36 Million

According to IGC Pharma's latest financial reports the company has โ‚น22.36 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

IGC Pharma - Cash on Hand chart (from 2006 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31โ‚น34.61 M-65.34%
2024-03-31โ‚น99.87 M-63.71%
2023-03-31โ‚น0.27 B-65.34%
2022-03-31โ‚น0.79 B-25.85%
2021-03-31โ‚น1.07 B15.21%
2020-03-31โ‚น0.92 B-47.73%
2019-03-31โ‚น1.77 B1547.23%
2018-03-31โ‚น0.10 B-31.17%
2017-03-31โ‚น0.15 B58.81%
2016-03-31โ‚น98.75 M92.24%
2015-03-31โ‚น51.37 M-16.58%
2014-03-31โ‚น61.58 M6.59%
2013-03-31โ‚น57.77 M101.84%
2012-03-31โ‚น28.62 M-59.33%
2011-03-31โ‚น70.37 M87.2%
2010-03-31โ‚น37.59 M-65.07%
2009-03-31โ‚น0.10 B-76.44%
2008-03-31โ‚น0.45 B-84.27%
2007-03-31โ‚น2.90 B-1.59%
2006-03-31โ‚น2.95 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Sterling Infrastructure
STRL
โ‚น44.20 B 197,538.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
โ‚น14.81 B 66,155.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
โ‚น99.46 B 444,610.64%๐Ÿ‡บ๐Ÿ‡ธ USA